Clinical Trial Update: Immune Abnormalities in Sporadic Inclusion Body Myositis

View source ↗

Summary

This completed clinical trial update summarizes immune abnormalities observed in sporadic inclusion body myositis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sporadic Inclusion Body Myositis

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Sporadic, Inclusion Body | Status: COMPLETED